The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Jay L. Goldstein

Department of Medicine

University of Illinois at Chicago


IL 60612



Name/email consistency: high



  • Department of Medicine, University of Illinois at Chicago, Chicago, IL 60612, USA. 2000 - 2011


  1. Haemoglobin decreases in NSAID users over time: an analysis of two large outcome trials. Goldstein, J.L., Chan, F.K., Lanas, A., Wilcox, C.M., Peura, D., Sands, G.H., Berger, M.F., Nguyen, H., Scheiman, J.M. Aliment. Pharmacol. Ther. (2011) [Pubmed]
  2. Clinical trial: the incidence of NSAID-associated endoscopic gastric ulcers in patients treated with PN 400 (naproxen plus esomeprazole magnesium) vs. enteric-coated naproxen alone. Goldstein, J.L., Hochberg, M.C., Fort, J.G., Zhang, Y., Hwang, C., Sostek, M. Aliment. Pharmacol. Ther. (2010) [Pubmed]
  3. Clinical trial: endoscopic evaluation of naproxen etemesil, a naproxen prodrug, vs. naproxen - a proof-of-concept, randomized, double-blind, active-comparator study. Goldstein, J.L., Jungwirthová, A., David, J., Spindel, E., Bouchner, L., Pešek, F., Searle, S., Skopek, J., Grim, J., Ulč, I., Sewell, K.L. Aliment. Pharmacol. Ther. (2010) [Pubmed]
  4. Endoscopic ulcer rates in healthy subjects associated with use of aspirin (81 mg q.d.) alone or coadministered with celecoxib or naproxen: a randomized, 1-week trial. Goldstein, J.L., Aisenberg, J., Zakko, S.F., Berger, M.F., Dodge, W.E. Dig. Dis. Sci. (2008) [Pubmed]
  5. Clinical trial: healing of NSAID-associated gastric ulcers in patients continuing NSAID therapy - a randomized study comparing ranitidine with esomeprazole. Goldstein, J.L., Johanson, J.F., Hawkey, C.J., Suchower, L.J., Brown, K.A. Aliment. Pharmacol. Ther. (2007) [Pubmed]
  6. Small bowel mucosal injury is reduced in healthy subjects treated with celecoxib compared with ibuprofen plus omeprazole, as assessed by video capsule endoscopy. Goldstein, J.L., Eisen, G.M., Lewis, B., Gralnek, I.M., Aisenberg, J., Bhadra, P., Berger, M.F. Aliment. Pharmacol. Ther. (2007) [Pubmed]
  7. Intragastric acid control in non-steroidal anti-inflammatory drug users: comparison of esomeprazole, lansoprazole and pantoprazole. Goldstein, J.L., Miner, P.B., Schlesinger, P.K., Liu, S., Silberg, D.G. Aliment. Pharmacol. Ther. (2006) [Pubmed]
  8. The impact of low-dose aspirin on endoscopic gastric and duodenal ulcer rates in users of a non-selective non-steroidal anti-inflammatory drug or a cyclo-oxygenase-2-selective inhibitor. Goldstein, J.L., Lowry, S.C., Lanza, F.L., Schwartz, H.I., Dodge, W.E. Aliment. Pharmacol. Ther. (2006) [Pubmed]
  9. A multicenter, randomized, double-blind, active-comparator, placebo-controlled, parallel-group comparison of the incidence of endoscopic gastric and duodenal ulcer rates with valdecoxib or naproxen in healthy subjects aged 65 to 75 years. Goldstein, J.L., Aisenberg, J., Lanza, F., Schwartz, H., Sands, G.H., Berger, M.F., Pan, S. Clin. Ther (2006) [Pubmed]
  10. Impact of adherence to concomitant gastroprotective therapy on nonsteroidal-related gastroduodenal ulcer complications. Goldstein, J.L., Howard, K.B., Walton, S.M., McLaughlin, T.P., Kruzikas, D.T. Clin. Gastroenterol. Hepatol. (2006) [Pubmed]
  11. Cyclooxygenase-2 specific inhibitors and upper gastrointestinal tolerability in patients with osteoarthritis receiving concomitant low dose aspirin: pooled analysis of 2 trials. Goldstein, J.L., Bello, A.E., Spalding, W., Suh, S., Fort, J.G. J. Rheumatol. (2005) [Pubmed]
  12. Video capsule endoscopy to prospectively assess small bowel injury with celecoxib, naproxen plus omeprazole, and placebo. Goldstein, J.L., Eisen, G.M., Lewis, B., Gralnek, I.M., Zlotnick, S., Fort, J.G. Clin. Gastroenterol. Hepatol. (2005) [Pubmed]
  13. Challenges in managing NSAID-associated gastrointestinal tract injury. Goldstein, J.L. Digestion (2004) [Pubmed]
  14. Reduced incidence of upper gastrointestinal ulcer complications with the COX-2 selective inhibitor, valdecoxib. Goldstein, J.L., Eisen, G.M., Agrawal, N., Stenson, W.F., Kent, J.D., Verburg, K.M. Aliment. Pharmacol. Ther. (2004) [Pubmed]
  15. Ulcer recurrence in high-risk patients receiving nonsteroidalanti-inflammatory drugs plus low-dose aspirin: results of a post HOC subanalysis. Goldstein, J.L., Huang, B., Amer, F., Christopoulos, N.G. Clin. Ther (2004) [Pubmed]
  16. A comparison of the upper gastrointestinal mucosal effects of valdecoxib, naproxen and placebo in healthy elderly subjects. Goldstein, J.L., Kivitz, A.J., Verburg, K.M., Recker, D.P., Palmer, R.C., Kent, J.D. Aliment. Pharmacol. Ther. (2003) [Pubmed]
  17. Dyspepsia tolerability from the patients' perspective: a comparison of celecoxib with diclofenac. Goldstein, J.L., Eisen, G.M., Burke, T.A., Peña, B.M., Lefkowith, J., Geis, G.S. Aliment. Pharmacol. Ther. (2002) [Pubmed]
  18. Who needs prophylaxis of nonsteroidal anti-inflammatory drug-induced ulcers and what is optimal prophylaxis?. Goldstein, J.L. Eur. J. Gastroenterol. Hepatol (2000) [Pubmed]
WikiGenes - Universities